InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the detailed record of transactions filed by Ryan Charles S.. Director active across 1 company, notably Quince Therapeutics, Inc.. In total, 1 filings have been recorded. Breakdown: 1 buy · 0 sell. Total volume traded: €28k. Activity tracked since 20 August 2024. The latest transaction was disclosed on 20 August 2024 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
1 of 1 declaration